ATE327234T1 - Sulfonamidderivate als antipsychotische mittel - Google Patents

Sulfonamidderivate als antipsychotische mittel

Info

Publication number
ATE327234T1
ATE327234T1 AT03757936T AT03757936T ATE327234T1 AT E327234 T1 ATE327234 T1 AT E327234T1 AT 03757936 T AT03757936 T AT 03757936T AT 03757936 T AT03757936 T AT 03757936T AT E327234 T1 ATE327234 T1 AT E327234T1
Authority
AT
Austria
Prior art keywords
sub
sup
alkyl
cycloalkyl
hydroxy
Prior art date
Application number
AT03757936T
Other languages
German (de)
English (en)
Inventor
Ian Thomson Forbes
Andrew Derrick Gribble
Andrew P Lightfoot
Andrew H Payne
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0223226A external-priority patent/GB0223226D0/en
Priority claimed from GB0223236A external-priority patent/GB0223236D0/en
Priority claimed from GB0314627A external-priority patent/GB0314627D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE327234T1 publication Critical patent/ATE327234T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03757936T 2002-10-07 2003-10-06 Sulfonamidderivate als antipsychotische mittel ATE327234T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0223226A GB0223226D0 (en) 2002-10-07 2002-10-07 Compounds
GB0223236A GB0223236D0 (en) 2002-10-07 2002-10-07 Compouds
GB0314627A GB0314627D0 (en) 2003-06-23 2003-06-23 Novel compounds

Publications (1)

Publication Number Publication Date
ATE327234T1 true ATE327234T1 (de) 2006-06-15

Family

ID=32073912

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03757936T ATE327234T1 (de) 2002-10-07 2003-10-06 Sulfonamidderivate als antipsychotische mittel

Country Status (8)

Country Link
US (1) US7122538B2 (https=)
EP (1) EP1549639B1 (https=)
JP (1) JP2006504794A (https=)
AT (1) ATE327234T1 (https=)
AU (1) AU2003273969A1 (https=)
DE (1) DE60305519T2 (https=)
ES (1) ES2264003T3 (https=)
WO (1) WO2004031181A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058328A1 (en) * 2003-12-18 2005-06-30 Abbott Gmbh & Co. Kg Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
US20050137186A1 (en) * 2003-12-18 2005-06-23 Abbott Gmbh & Co. Kg. Tetrahydrobenzazepines and their use
WO2007022933A1 (en) * 2005-08-22 2007-03-01 Glaxo Group Limited Triazole derivatives as modulators of dopamine d3 receptors
EP1837332A1 (en) * 2006-03-23 2007-09-26 Laboratorios Del Dr. Esteve, S.A. Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
WO2007140213A1 (en) 2006-05-26 2007-12-06 Forest Laboratories Holdings Limited Pyridoazepine derivatives
US20070293475A1 (en) * 2006-06-20 2007-12-20 Alcon Manufacturing Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
SG11201906289YA (en) * 2017-01-13 2019-08-27 Sumitomo Dainippon Pharma Co Ltd Therapeutic agent for non-motor symptoms associated with parkinson's disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792785B (en) * 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
GB9926302D0 (en) 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
WO2001045694A1 (en) * 1999-12-21 2001-06-28 Smithkline Beecham Corporation Urotensin-ii receptor antagonists
DE10053799A1 (de) 2000-10-30 2002-05-08 Bayer Ag Verwendung von Tetrahydroisochinolinsulfonamiden
KR20040081201A (ko) * 2002-02-13 2004-09-20 글락소 그룹 리미티드 항정신병제로서 벤젠술폰아미드 유도체

Also Published As

Publication number Publication date
EP1549639A1 (en) 2005-07-06
WO2004031181A1 (en) 2004-04-15
AU2003273969A1 (en) 2004-04-23
EP1549639B1 (en) 2006-05-24
ES2264003T3 (es) 2006-12-16
US20060063757A1 (en) 2006-03-23
DE60305519D1 (de) 2006-06-29
DE60305519T2 (de) 2006-11-23
US7122538B2 (en) 2006-10-17
JP2006504794A (ja) 2006-02-09

Similar Documents

Publication Publication Date Title
EA200600892A1 (ru) Новые хинолиновые производные
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
CR20140368A (es) Derivados y composiciones de isoindol 4´-0-sustituidos, composiciones que las comprenden y metodos de uso de los mismos (divisional 11036)
NO20082101L (no) Pyrido-, pyrazo- og pyrimido-pyrimidinderivater som mTor inhibitorer
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
EP1724262A4 (en) 1- (2H) -ISOCHINOLONDERIVAT
DE60027648D1 (de) Sulfonamide enthaltende indolderivate
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
EA200500814A1 (ru) Производные пирролопиримидина
MA27040A1 (fr) Nucleosides substitues en 4'
DK1261602T3 (da) Imidazol-2-carboxamidderivater som Raf-kinaseinhibitorer
DE602006011752D1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
HN2002000028A (es) Pirimidinas inhibidoras de metaloproteinasas
EA200700099A1 (ru) Производные пиридина
ATE442356T1 (de) 1-essigsäureindolderivate mit pgd2- antagonistischer wirkung
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
AR040126A1 (es) Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
DE60014394D1 (de) Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
NO20040589L (no) Arylsulfonylderivater med 5-HT6 reseptor affinitet.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties